A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

Cancer cell phenotypes evolve during a tumor's treatment. In some cases, tumor cells acquire cancer stem cell-like (CSL) traits such as resistance to chemotherapy and diminished differentiation; therefore, targeting these cells may be therapeutically beneficial. In this study we show that in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Feng, Liu, Jiayi, Brady, Samuel W., Cosgrove, Patrick A., Nath, Aritro, McQuerry, Jasmine A., Majumdar, Sumana, Moos, Philip J., Chang, Jeffrey T., Kahn, Michael, Bild, Andrea H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689336/
https://www.ncbi.nlm.nih.gov/pubmed/33221681
http://dx.doi.org/10.1016/j.tranon.2020.100946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689336/
https://www.ncbi.nlm.nih.gov/pubmed/33221681
http://dx.doi.org/10.1016/j.tranon.2020.100946

Ejemplares similares